Vedanta's BALCO Medical Centre wins Cancer Grand Challenges Award

Photo:Representative Image

Vedanta's BALCO Medical Center (BMC), a new leader in Indian oncology, has reached a historic milestone by becoming India's first partner to win the prestigious Excellence in Cancer Grand Challenges Award.

This award, which raised $25 million for cancer research, reflects BMC's position as a pioneering institution in the Indian oncology landscape. PROSPECT, a collaborative team of doctors, advocates, and scientists from BALCO Medical Center and other renowned institutions worldwide, will address early cancer.

Jyoti Agarwal, President of Vedanta Medical Research Foundation, said, “Cancer. " I am honored to receive this prestigious award for my great work in eradication," he said with gratitude. Over the past six years, BMC's leaders, employees, and stakeholders have worked hard to provide access to the best technology and ensure that patients and communities are safe and confident. This support from Cancer Grand Challenges not only continues our work but also strengthens it. With collaborative efforts, I am confident we can positively contribute to the healthcare landscape.”

Team PROSPECT is one of five global teams funded this year by Cancer Grand Challenges, founded in 2020 by Cancer Research UK and the National Cancer Institute US, to invite diverse, world-class research teams to come together, think differently, and take on some of cancer’s toughest challenges. The teams will be funded by Cancer Research UK, the National Cancer Institute, the Bowelbabe Fund for Cancer Research UK, and the Institute of National Du Cancer through Cancer Grand Challenges, with a total investment of $125 million to tackle some of the toughest challenges in cancer research.

“Together with our network of visionary partners and research leaders, Cancer Grand Challenges unites the world's brightest minds across boundaries and disciplines and aims to overcome cancer’s toughest problems,” said Dr. David Scott, Director of Cancer Grand Challenges. “With this investment, our largest to date, we continue to grow our global research community and fund new teams that have the potential to surface discoveries that could positively impact cancer outcomes.”

Vedanta’s BALCO Medical Centre, a state-of-the-art tertiary care oncology facility in Central India, has been at the forefront of cancer care, providing multidisciplinary treatment and support. The institution is recognized as a referral center for advanced radiation therapy, brachytherapy, nuclear medicine, surgeries, chemotherapy, and many more.